12/23/2025
The funding, administered by DOH, will be distributed through competitive grants to qualifying institutions conducting research on neurodegenerative diseases, such as Alzheimer’s disease, Amyotrophic Lateral Sclerosis (ALS), Parkinson’s disease, and related disorders. Applications for the grant program are expected to open in early 2026. With world-class research institutions across the Commonwealth, Pennsylvania is uniquely positioned to translate scientific discovery into earlier detection, better treatments, and ultimately cures.
For the first time ever, Pennsylvania will spend $5 million on neurodegenerative disease research, marking a major step forward for older adults, caregivers, and families across the Commonwealth. “By making this first-ever investment in neurodegenerative disease research, we’re accelerating the ...